Scott Rocklage
InvestorFounding Partner at 5AM Ventures
Palm Beach Gardens, Florida
Writes $100K – $5M checks · typically $1.5M
About
Scott Rocklage, MIT PhD chemist (Schrock lab) and ex-CEO of Cubist and Nycomed Salutar, combines operator experience, a global US/Europe/Asia board footprint, and partners with technical founders to shape medicines.
Invests in
BiotechHealthtechMedical Devices
Experience
- 5AM VenturesFounding Partnercurrent2018 — present
Education
- Massachusetts Institute of TechnologyDoctor of Philosophy - PhD, Chemistry
- U.C. Berkeley
Same school
Also attended Massachusetts Institute of Technology849
+ 843 more
Deals · 5
Kinestral TechnologiesBoard seat
via 5AM Ventures · filed Jun 2018 · $54.6M raise
Cidara TherapeuticsBoard seat
via 5AM Ventures · filed Oct 2017 · $20.2M raise
RennoviaBoard seat
via 5AM Ventures · filed Feb 2017 · $6M raise
PulmatrixBoard seat
via 5AM Ventures · filed Jun 2015 · $210K raise
Pulmatrix OperatingBoard seat
via 5AM Ventures · filed Jun 2015 · $34.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at 5AM Ventures
Network1
Investors connected to Scott in public investor directories — a warm-intro map.











